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Background: Coronary artery bypass grafting can now be performed with or without
cardiopulmonary bypass. Our objective was to determine whether off-pump coro-
nary artery bypass grafting is associated with better early outcomes compared with
conventional coronary artery bypass grafting.
Methods: In 4 centers with off-pump coronary surgery experience, a retrospective
analysis of all coronary artery bypass grafting in a 3-year period was performed.
Groups were compared to determine selection criteria, mortality, and morbidity,
then computer-matched by propensity score to control for selection bias. Multivar-
iate logistic regression identified risk factors predictive of mortality. Specific sub-
groups most likely to benefit were identified.
Results: In all, 17,401 isolated coronary artery bypass grafts were performed, 7283
(41.9%) off-pump coronary artery bypass grafts and 10,118 (58.1%) conventional
coronary artery bypass with cardiopulmonary bypass. Factors determining selection of
patients for off-pump coronary artery bypass grafting included female gender (55.5% vs
44.5%), preexisting renal failure (57.0% vs 43.0%), and reoperations (52.6% vs 47.4%).
Operative mortality was 2.8%; off-pump coronary artery bypass grafting versus con-
ventional coronary artery bypass with cardiopulmonary bypass (1.9% vs 3.5%, P 
.001) had the same predicted risk. Of the patients with multivessel disease, 11,548 were
matched by propensity scoring. Mortality was significantly less in the off-pump coro-
nary artery bypass grafting group (2.8% vs 3.7%, P  .001). By multivariate logistic
regression analysis of the matched sample, predictors for mortality were female gender
(odds ratio 1.83, confidence interval 1.37-2.44), preexisting renal failure (odds ratio
2.85, confidence interval 2.64-4.95), history of stroke (odds ratio 1.74, confidence
interval 1.08-2.80), previous coronary artery bypass grafting surgery (odds ratio 4.22,
confidence interval 2.92-6.09), use of cardiopulmonary bypass (odds ratio 2.08, confi-
dence interval 1.52-2.83), and recent myocardial infarction (odds ratio 2.31, confidence
interval 1.68-3.22). Cardiopulmonary bypass was predictive of mortality in reoperations,
female patients, and patients aged 75 years. Off-pump coronary artery bypass grafting
was associated with less morbidity, including reductions in blood transfusion (32.6% vs
40.6%, P  .001), stroke (1.4% vs 2.1%, P  .002), renal failure (2.6% vs 5.2%, P 
.001), pulmonary complications (4.1% vs 9.5%, P .001), reoperation (1.7% vs 3.2%,
P  .001), atrial fibrillation (21.1% vs 24.99%, P  .001), and gastrointestinal
complications (3.6% vs 4.8%, P  .02).
Conclusion: In 4 centers with beating-heart operation experience, there is an overall
early benefit in off-pump surgery, especially in patients traditionally considered at
high risk for coronary artery bypass grafting.
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Although initial surgical revascularizationof the coronary arteries was performed ona beating heart in the 1960s, the introduc-tion of the heart-lung machine createdoptimal operative conditions of a blood-less, motionless operative field and al-
lowed coronary artery bypass grafting (CABG) to be done
consistently with generally good results in most patients.1,2
Although a few centers persisted in applying beating-heart
surgery in selective patients, the preponderance of CABG
has been performed with cardiopulmonary bypass (CABG-
CPB) or “on-pump” over the past 35 years.3,4 Generally
excellent results have been achieved with CABG; however,
significant mortality and morbidity still exist.5 In the mid-
1990s interest in beating-heart techniques experienced a
resurgence in an attempt to decrease the morbidity associ-
ated with CABG without jeopardizing the benefits. Tech-
nological advancements significantly facilitated the perfor-
mance of beating-heart surgery compared with the initial
experience 30 years previously.6,7 Although estimates of the
percent of CABG now performed by beating-heart ap-
proaches in the United States range from 20% to 25%, only
a few small single-center randomized trials exist comparing
the results of coronary revascularization performed on-
pump (CABG-CPB) compared with off-pump (OP-
CAB).8-10 Large, randomized trials comparing the 2 tech-
niques have been difficult to perform due to the reluctance
of patients, their referring physicians, and surgeons to par-
ticipate in a randomized trial. Therefore, to assess the im-
pact of beating-heart technique outcomes in CABG, the
results of off-pump and on-pump coronary surgery were
examined and compared in 4 large centers with significant
beating-heart surgery experience (at least 5 years, 500
cases).
Methods
Database Development
The study employed a retrospective analysis of data pooled from 4
major cardiac surgery centers in the United States (Cardiopulmo-
nary Research Science and Technology Institute, Medical City
Dallas Hospital, Dallas, Tex; Lenox Hill Hospital, New York, NY;
Cardiac Surgical Associates, PA, Minneapolis, Minn; Washington
Hospital Center, Washington, DC). Centers were selected based on
the volume of CABG cases performed per year and on surgeon
experience with beating-heart techniques at each institution. The
analysis was limited to the years 1999 through 2001 to limit
possible bias associated with the centers’ early learning experi-
ence. All patients undergoing initial or reoperative isolated CABG
were included in the database.
In the 4 study centers, data were prospectively collected on all
patients who had cardiac surgery; date were subsequently entered
into a relational database. Three of the 4 centers used standardized
criteria and definitions set forth by the Society of Thoracic Sur-
geons (STS) for measuring the study variables.5 The fourth insti-
tution collected data as mandated by the New York State Depart-
ment of Health. Data from this institution were recoded as
necessary to match the STS definitions. STS data elements that
were not present in the New York State data set were eliminated.
Data elements for which 10% or more data was missing were also
excluded.
The resulting database consisted of 20 preoperative risk factors
(Table 1). The Parsonnet risk stratification model was used to
broadly define differences between treatment groups that might
influence selection and patient outcomes.11 The Parsonnet risk
stratification is a logistic regression model in which 47 potential
risk factors are considered to determine risk preoperatively. This
model is a tool to compare expected mortality rates with observed
mortality. Perioperative data collected and compared between
groups are listed in Table 2. Complete data were available for
17,401 patients during the study period, including 7283 (41.9%)
patients who underwent OPCAB and 10,118 (58.1%) patients who
underwent CABG-CPB. The total number of cases for each study
center as well as the number and percent performed by each
technique are listed in Table 3.
Description of the Sample
Patients were grouped and compared according to surgical treat-
ment, OPCAB versus CABG-CPB. Preoperative patient character-
istics and individual risk factors, intraoperative courses, and oper-
ative outcomes were compared by univariate and multivariate
analyses using SPSS statistical software (SPSS Inc, Chicago, Ill).
Data are reported as a percentage or as a mean  standard
deviation. Univariate comparisons were computed using the Man-
tel-Haenszel chi-square test of general association unless other-
wise stated. Fisher exact test was used in comparisons of small cell
counts. Ordinal categorical data were compared using the Coch-
ran-Armitage test for trends. Comparisons of continuous data were
done using the Wilcoxon rank-sum test. All tests are two-sided.
Demographic characteristics and preoperative risk factors of
the off-pump and on-pump groups were compared using chi-
TABLE 1. Preoperative risk factors included in the data-
base
● Age
● Gender
● Race
● Body mass index
● Congestive heart failure
● Chronic lung disease
● Renal failure
● Dialysis
● History of cerebrovascular accident
● Cerebrovascular disease
● Diabetes
● Peripheral vascular disease
● Ejection fraction
● Left main disease
● Myocardial infarction
● When myocardial infarction occurred
● Number of diseased vessels
● Previous coronary artery bypass grafting
● Surgical priority
● Parsonnet risk scores
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squared and Pearson t test. Results indicated the groups were
statistically different on several important characteristics (Table 4).
Because the decision to perform CABG on- or off-pump at all 4
centers was at the surgeons’ discretion, propensity score matching
was conducted for treatment and control groups to control for
selection bias.12,13
A multivariate logistic regression model was estimated to com-
pute the probability of OPCAB selection for all multivessel cases
in the sample. Independent variables used to create the model are
listed in Table 5. A propensity score was calculated for each
patient by solving the saturated model for the probability of
off-pump bypass. Using only the propensity score, on-pump cases
were matched to off-pump cases using a greedy matching strategy.
For this procedure, matching to 5 decimal points was initially
performed, followed by 4, 3, 2, and 1 decimal-point matching.
Off-pump cases that could not be matched by propensity score
within 1 decimal point with a comparable on-pump case were
considered unmatched. The treatment-control matching procedure
yielded a sample of 11,548 cases, with 5774 OPCAB and 5774
CABG-CPB subjects. Repeated analysis of the demographic char-
acteristics and preoperative risk factors indicated that the OPCAB
and CABG-CPB groups were comparable in the matched sample.
Statistical Modeling
Data from the matched sample were entered into a multivariate
logistic regression model with mortality as the dependent variable.
In this step, the backward elimination method was used to identify
significant predictors of operative mortality from the set of 20
preoperative risk factors along with use of cardiopulmonary by-
pass as the independent variables. To identify subgroups most
likely to benefit from beating-heart surgery, a series of alternate
regression models were tested with mortality and major morbidi-
ties as dependent variables.
Results
In the 3-year period between 1999 and 2001, 17,401 iso-
lated CABG procedures were performed in the 4 institu-
tions. Cases with a concomitant procedure (eg, valve oper-
ations) were eliminated from this analysis. Volume of
CABG procedures performed without cardiopulmonary by-
pass was 7283 (41.9%) and ranged between 29.2% and
86.2% among the 4 institutions (Table 3). Factors predicting
preferential selection are listed in Table 4. There were
12,761 (73.4%) men and 4640 (26.6%) women with a mean
age 64.39  10.78 (range 24-99). Reoperative procedures
constituted 6.5% of the whole sample, 6.9% of the OPCAB
group, and 6.1% of the CABG-CPB cohort. Operative mor-
TABLE 2. Outcomes included in the database
● 30-day mortality
● Complications (yes or no)
● Septicemia
● Deep sternal wound infection
● Permanent neurologic deficit
● Transient stroke
● Perioperative myocardial infarction
● Reoperation for bleeding
● Reoperation for graft occlusion
● New-onset atrial fibrillation
● Cardiac arrest
● Anticoagulation complications
● Gastrointestinal complications
● Heart block
● Multisystem failure
● Cardiac tamponade
● Respiratory complication
● Renal failure
TABLE 3. Number of cases and proportion of OPCAB per
study center
Study center
Total number of
CABG cases
OPCAB
cases, n
(%)
CABG-CPB
cases, n
(%)
A 6105 2050 (33.6) 4055 (66.4)
B 4106 1199 (29.2) 2907 (70.8)
C 5931 2948 (49.7) 2983 (50.3)
D 1260 1086 (86.2) 174 (13.8)
OPCAB, Off-pump coronary artery bypass; CABG, coronary artery bypass
grafting; CABG-CPB, coronary artery bypass grafting with cardiopulmonary
bypass.
TABLE 4. Differences in preoperative risk factors between
unmatched study groups
Risk factors
On-pump
group (%)
Off-pump
group (%) P values
CHF 5.3 18.7 .001
Chronic lung disease 27.7 43.9 .001
Renal failure 2.6 3.2 .05
CVA 4.9 6.1 .004
Cerebrovascular disease 7.0 8.9 .001
Peripheral vascular disease 6.8 12.7 .001
Previous CABG 6.1 6.9 .001
CHF, Congestive heart failure; CVA, cerebrovascular accident; CABG,
coronary artery bypass grafting.
TABLE 5. Independent variables used in propensity score
matching
Gender
Renal failure
Hypertension
CVA
Congestive heart failure
Chronic lung disease
Peripheral vascular disease
Cerebrovascular disease
Previous CAB
MI
Left main disease
Surgical priority (elective, nonelective)
CVA, Cerebrovascular accident; CAB, coronary artery bypass; MI, myo-
cardial infarction.
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tality of OPCAB versus CABG-CPB was 4.5% versus
11.6% in the reoperative group (P  .001).
Overall mortality for the study population was 2.8%.
Parsonnet risk scores indicated no significant difference
between the 2 groups (OPCAB vs CABG-CPB, 5.8 vs 6.6).
Although Parsonnet risk scores predicted equal expected
mortality in each group, observed mortality for the patients
who underwent CABG-CPB compared with OPCAB was
3.5% versus 1.9% (P  .001). Ten percent of the CABG
procedures were single-vessel bypasses with 23.3% off-
pump and with a mortality of 0.9% compared with single-
vessel operations performed with cardiopulmonary bypass
with a mortality of 3.3% (P  .001). However, this higher
mortality of single-vessel disease operated with cardiopul-
monary bypass is explained by a higher portion of emer-
gency/salvage patients in that group.
To minimize the role of selection bias, 11,458 multives-
sel disease patients were computer-matched by propensity
scoring. The mean number of grafts per patient did not
differ significantly between the 2 matched groups, 2.95 in
the on-pump group and 2.83 in the off-pump group. Using
the variables listed in Table 5, Parsonnet risk scoring of the
2 groups indicated identical predicted risks both in the
whole sample and by institution as is indicated in Table 6.
Predicted risk of the propensity matched sample in each
group is listed in Table 7. Despite the same predicted risk,
the operative mortality was less in the OPCAB group (2.0%
vs 3.7%, P .001). Multivariate logistic regression analysis
of the propensity-matched sample indicated that the 6 vari-
ables in Table 8 were independent predictors of mortality,
including the use of CPB (odds ratio 2.08, confidence in-
terval 1.52-2.83, P  .001).
Predictors of mortality in both groups included female
gender, redo procedures, and recent myocardial infarction
(Tables 9 and 10). Dialysis-dependent renal failure (but not
non–dialysis-dependent renal insufficiency) was also a pre-
dictor in the off-pump surgery group while any preoperative
renal failure, stroke, peripheral vascular disease, and remote
myocardial infarction were also predictive in the on-pump
group. A series of alternate models was tested for unique
sets of predictors of mortality. CPB was predictive of mor-
tality in patient age  75 years, in patients undergoing
reoperative CABG, and in women (Table 11).
Chi-squared analysis documented significant reduction
in mortality (P  .001) as well as significant reductions in
morbidity in the off-pump group, including: reduced total
use of blood products (P  .001), overall complications (P
 .001), permanent neurologic deficit (P  .002), reopera-
tion for bleeding (P  .001), new-onset atrial fibrillation (P
 .001), gastrointestinal complications (P  .02), pneumo-
nia (P  .001), respiratory complications (P  .001), and
renal failure (P  .001) (Table 12 ). Further, it is notewor-
thy that the off-pump group experienced no increased inci-
dence of any complication compared with the on-pump
group.
Discussion
Evidence-based medicine mandates the prospective ran-
domized trial as the most accurate tool for determining a
treatment benefit compared with a control population.14,15
TABLE 7. Predicted risk of mortality for the propensity-
matched sample*
Mean (%) Standard deviation
Sample 6.39 5.88
OPCAB 6.46 5.91
CABG-CPB 6.33 5.86
OPCAB, Off-pump coronary artery bypass; CABG-CPB, coronary artery
bypass grafting with cardiopulmonary bypass.
*Calculated from the logit of the Parsonnet score; formula published on the
SFAR.org website.
TABLE 8. Predictors of mortality for the propensity-
matched sample
Variable OR CI P value
Female gender 1.83 1.37-2.44 .001
Renal failure 2.85 1.64-4.95 .001
CVA 1.74 1.08-2.80 .02
Redo 4.22 2.92-6.09 .001
CPB used 2.08 1.60-2.83 .001
Recent MI (7 days) 2.31 1.68-3.22 .001
OR, Odds ratio; CI, confidence interval; CVA, cerebrovascular accident;
CPB, cardiopulmonary bypass; MI, myocardial infarction.
TABLE 9. Predictors of mortality for the OPCAB group
Variable OR CI P value
Female gender 2.23 1.36-3.64 .001
Dialysis 5.94 1.97-17.87 .002
Redo 3.66 1.86-7.21 .001
Recent MI 2.54 1.49-4.33 .001
OPCAB, Off-pump coronary artery bypass; OR, odds ratio; CI, confidence
interval; MI, myocardial infarction.
TABLE 6. Parsonnet risk scores (mean/SD) for the propen-
sity-matched sample
Score
On-pump
group
Off-pump
group
Sample 12.1 (7.3) 12 (7.3) 12.1 (7.3)
Center A 14.5 (6.7) 14.6 (6.7) 14.3 (6.7)
Center B 11.0 (7.4) 11.2 (7.4) 10.7 (7.5)
Center C 10.5 (7.5) 10.3 (7.0) 10.5 (7.2)
Center D 11.0 (7.5) 10.1 (7.4) 11.2 (7.5)
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Trial costs and delay in obtaining an answer notwithstand-
ing, the generalizability of the results in a select study group
to the treatment population as a whole can be questioned.16
Specific problems conducting a randomized prospective
trial comparing on-pump with off-pump surgery include
little experience and expertise in off-pump techniques in
many major centers capable of randomizing patients and
performing such a study. There are 3 prospective random-
ized studies comparing on- and off-pump CABG.8-10 A total
of 879 patients combined have been enrolled in the 3 trials
with an operative mortality of 0.9% in the on-pump group
and 0.2% in the off-pump group. The outcomes for stroke in
the same meta-analysis shows an incidence of 0.9% on-
pump and 0.4% off-pump. Both outcomes, however, are
underpowered to show significance even in a meta-analysis.
There are many centers that have gained significant ex-
perience in off pump techniques. Consequently, their sur-
gical expertise is relatively equal in both treatment arms (on
vs off bypass). In these situations, there is an inability or
unwillingness to randomize due to a perception of clinical
benefit in off-pump surgery, either by the operating surgeon,
the referring physician, or by the patients themselves who
have frequently been referred to these institutions specifi-
cally for off-pump surgery. Hence, we hoped to gain insight
into the impact of off-pump surgery on early CABG out-
comes by a retrospective analysis using propensity score
computer matching of cases from 4 institutions who had
gained significant experience in beating-heart CABG. Al-
though all the major risk factors for outcomes were able to
be accounted for in the propensity matching, the role of the
individual surgeon as a variable could not be included.
Although all surgeons in each institution performed both
on- and off-pump CABG, there was a predilection for some
surgeons to perform a greater proportion off-pump while
others performed a greater proportion on-pump. The indi-
vidual surgeon is an independent variable affecting out-
comes; however, in this analysis it was not possible to
construct a propensity model that accounted for that vari-
able.
The result of this analysis indicates that off-pump sur-
gery is associated with significantly less operative mortality
and morbidity than on-pump surgery and that the use of
cardiopulmonary bypass is an independent risk factor for
mortality in centers that have attained significant experience
with beating-heart techniques.
A significant shortcoming of this study is that the format
of the data collection tool does not allow for an intention-
to-treat analysis. On occasion, due to intraoperative hemo-
dynamic instability or technical issues limiting access to
target coronary vessels, conversion from off-pump to on-
pump is necessary to complete the procedure. Prior to the
year 2000, the STS database, which was the collection tool
in 3 of the 4 centers, did not collect conversion from
off-pump to on-pump surgery data. Hence, in these 3 insti-
tutions in 1999, analysis of patients whose operation was
initiated off-pump and converted intraoperatively to the use
of cardiopulmonary bypass were included in the on-pump
group, thereby conceivably adversely affecting the out-
comes of the CABG-CPB cohort. Therefore, to determine
how this factor might impact the data, the database was
analyzed separately for the years 2000 and 2001, for which
conversion data was available for all 4 centers. This allowed
analysis for patients in 2000 and 2001 to be included on an
intention-to-treat basis, including the OPCAB conversions
with the OPCAB group. The conversion rate was 2.9% and
including these 172 patients with the off-pump group rather
than the on-pump group for analysis resulted in no signifi-
cant differences in outcomes.
It is also important to note that these data include only
early procedural outcomes and do not address longer-term
follow-up. Despite early improved outcomes in operative
mortality and morbidity, long-term graft patency and event-
free survival remain unknown. Although early angiographic
TABLE 11. Predictors of mortality in specific subgroups
Variable OR CI P value
Age 75*
Female gender 1.99 1.15-3.46 .02
Redo 4.60 2.25-9.40 .001
CPB used 2.13 1.20-3.76 .01
Redo CABG†
Dialysis 17.87 9.95-32.07 .05
CVA 3.08 1.04-9.13 .04
Recent MI 3.12 1.39-7.00 .006
CPB Used 3.37 1.59-7.17 .002
Women‡
Dialysis 4.57 1.79-11.7 .002
CVA 2.02 1.0-4.1 .05
Recent MI 2.7 1.65-4.73 .001
CPB Used 1.7 1.07-2.69 .02
Redo 3.88 1.94-7.76 .001
OR, Odds ratio; CI, confidence interval; CPB, cardiopulmonary bypass; CVA,
cerebrovascular accident; MI, myocardial infarction.
*n  1479 (20% of sample).
†n  460 (6.2% of sample).
‡n  1929 (26.1% of sample).
TABLE 10. Predictors of mortality for the CABG-CPB group
Variable OR CI P value
Female gender 1.74 1.21-2.49 .003
Renal failure 2.83 1.43-5.58 .003
CVA 2.00 1.12-3.57 .02
PVD 1.66 1.04-2.67 .04
Redo 4.70 3.03-7.36 .001
Old MI 1.59 1.06-2.38 .03
Recent MI 2.18 1.43-3.33 .001
CABG-CPB, Conventional coronary artery bypass with cardiopulmonary
bypass; OR, odds ratio; CI, confidence interval; CVA, cerebrovascular
accident; PVD, peripheral vascular disease; MI, myocardial infarction.
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graft patency has been demonstrated to be excellent,17 an
intermediate-term study is not as definitive.18 A subgroup
studied at 3 years demonstrates excellent left internal tho-
racic artery graft patency, but saphenous vein graft patency
to the posterior circulation using early generation stabiliza-
tion and exposure techniques was lower than one would
expect.
Certain results are worthy of note. The first is that the use
of cardiopulmonary bypass is an independent risk factor for
mortality. Second, there appears to be a particular benefit to
avoiding CPB in those subgroups generally considered high
risk for CABG surgery, including the elderly, women, and
patients undergoing reoperative operations. Third, as well as
a mortality benefit, the performance of beating-heart sur-
gery is associated with a significant decrease in periopera-
tive morbidity including the need for blood transfusions,
return to the operating room for bleeding, respiratory com-
plications, and new-onset renal failure. A further potential
benefit of beating-heart surgery was hoped to be improved
neurologic outcomes. Indeed, this analysis demonstrates a
significant decrease in permanent neurologic deficit postop-
eratively in the OPCAB group (1.4 vs 2.1, P  .001).
Definitive outcomes analysis awaits a multicenter prospec-
tive randomized trial. However, due to the low incidence of
major adverse outcomes (eg, mortality, stroke), such a study
would require many thousands of patients to confer adequate
statistical power to detect differences between on- and off-
pump treatment groups. The only such study currently under-
way is the Veteran’s Administration cooperative study but it
will be many years before this study is completed and analyzed
and results made available for evaluation. Even then, those
results will be limited by the population studied as well as the
inexperience in beating-heart techniques in many of the cen-
ters. This study represents significant experience on the part of
centers who are extremely experienced and proficient in this
operation. These centers have advanced past learning curves
and represent a mature application of this technology. These
data, despite their methodological shortcomings, support a
benefit for OPCAB, which is consistent with numerous previ-
ous reports. In addition, OPCAB benefit persists despite ele-
vated risk among those patients preferentially operated on
off-pump. Ability to achieve superior outcomes in high-risk
patients in terms of mortality and across a number of morbidity
variables clearly speaks to the potential clinical benefit of this
operation. Although not randomized, this study adds to the
increasing body of patients and among sample sizes sufficient
to confer adequate statistical power for detection of differ-
ences.
We thank the Cardiopulmonary Research Science and Tech-
nology Institute (CRSTI), Medical City Dallas Hospital, Dallas,
Tex; Sherry Mullins, Lenox Hill Hospital, New York, NY; Rita
Considine, RN, MS, Joan Jennings, RN, MA, Cardiac Surgical
Associates, PA, Minneapolis, Minn; Carla Erickson, RN, MS,
Washington Hospital Center, Washington, DC; and Leanne Mc-
Kenna, RN.
TABLE 12. Outcomes from the propensity score-matched sample
Outcome Sample, n (%) CABG-CPB, n (%) OPCAB, n (%) P value*
Use of blood products 4659 (47.0) 3156 (40.6) 1503 (32.6) .001
Complications 4093 (40.9) 2997 (56.0) 1096 (23.5) .001
Septicemia 56 (0.6) 41 (0.8) 15 (0.3) .002
Deep sternal wound infection 51 (0.4) 33 (0.6) 18 (0.3) .02
Permanent neurologic deficit 202 (1.7) 123 (2.1) 79 (1.4) .002
Transient stroke 48 (0.6) 26 (0.6) 22 (0.5) NS
Perioperative MI 119 (1.0) 75 (1.3) 44 (0.8) .005
Reoperation for bleeding 248 (2.5) 169 (3.2) 79 (1.7) .001
Reoperation for graft occlusion 15 (0.2) 7 (0.1) 8 (0.2) NS
New-onset A-fib 2644 (23.1) 1439 (25.0) 1205 (21.1) .001
Cardiac arrest 145 (1.3) 92 (1.6) 53 (0.9) .001
GI complications 487 (4.2) 277 (4.8) 210 (3.6) .004
Multisystem failure 49 (0.5) 33 (0.6) 16 (0.3) .04
Cardiac tamponade 89 (0.8) 56 (1.0) 33 (0.6) .02
Pneumonia 318 (2.8) 206 (3.6) 112 (2.0) .001
Pulmonary embolus 38 (0.3) 18 (0.3) 20 (0.3) NS
Respiratory complication 787 (6.8) 551 (9.5) 236 (4.1) .001
Renal failure 453 (3.9) 300 (5.2) 153 (2.6) .001
Mortality 327 (2.8) 211 (3.7) 116 (2.0) .001
CABG-CPB, Conventional coronary artery bypass with cardiopulmonary bypass; OPCAB, off-pump coronary artery bypass; MI, myocardial infarction; A-fib,
atrial fibrillation; GI, gastrointestinal. One center records respiratory failure rather than pulmonary embolus or pneumonia; respiratory complication is a
composite variable that includes pneumonia, pulmonary embolus, or respiratory failure. If a subject experienced any one of these complications, then
respiratory complication  yes.
*P values in comparison of CABG-CPB and OPCAB categories.
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